<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Gentian violet: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Gentian violet: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Gentian violet: Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_patient" data-topicid="11956" href="/d/html/11956.html" rel="external">see "Gentian violet: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="13333" href="/d/html/13333.html" rel="external">see "Gentian violet: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F176039"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antibiotic, Topical;</li>
<li>
                        Antifungal Agent, Topical</li></ul></div>
<div class="block doa drugH1Div" id="F176033"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a474b86d-f618-403c-abc4-11a9a731c6ce">Candidiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Candidiasis:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oropharyngeal, mild disease (alternative agent) (off-label use): Topical solution (0.00165%):</b> Apply to affected area twice daily; swish in the mouth and retain for as long as possible (several minutes) before expectorating. Duration is for 7 to 14 days (HHS [OI adult 2021]; Mukherjee 2017).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="df80bfb6-0a7f-4cf0-9db5-9e736a551c3d">Topical infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical infection:</b>
<b>Topical:</b> Apply to affected area 1 to 3 times daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990022"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987295"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F176034"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F176036"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="13333" href="/d/html/13333.html" rel="external">see "Gentian violet: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e2dd9a93-adff-4292-9a40-bc73a19b0096">Oral candidiasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral candidiasis:</b> Limited data available: <b>Note: </b>Not the preferred treatment; ulceration and/or burns of the oral mucosa have been reported in neonates and young infants in as little as 4 days (John 1968; Piatt 1992; Slotkowski 1966); use with caution and limit use.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants: Topical: Topical solution (0.5% or 1%): Apply sparingly to affected area (under tongue or on oral lesion) once or twice daily for â‰¤3 days (Faber 1927; John 1968; Piatt 1992; Slotkowski 1966).</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Topical: Topical solution (0.5% to 2%): Apply to affected area twice daily (Gal 2007).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7031b9f5-9040-4287-a92f-2119a7878648">Topical dermal infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical dermal infection:</b> Infants, Children, and Adolescents: Topical: Topical Solution (1% or 2%): Apply to affected area 1 to 3 times daily.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51112177"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51112178"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F176022"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Allergic contact dermatitis (Docampo 1990), skin necrosis (Docampo 1990)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Mucous membrane abnormality (Docampo 1990)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local discomfort (Health Canada 2019), local pain (Health Canada 2019), local skin discoloration (Health Canada 2019)</p></div>
<div class="block coi drugH1Div" id="F176031"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">OTC labeling: When used for self-medication, do not use in the eyes or on ulcerative lesions.</p></div>
<div class="block war drugH1Div" id="F176019"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">â€¢ Staining: Use will result in staining of skin and clothing. Application to ulcerative lesions may result in tattooing.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">â€¢ Cancer: Animal studies have concluded that there is a potential link to cancer following oral exposure of gentian violet; cases of cancer in humans have not been reported (Health Canada 2019).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">â€¢ Appropriate use: When used for self-medication (OTC use), patients should notify healthcare provider if redness, irritation, swelling, or pain persists or increases, or if infection occurs. For external use only; avoid contact with eyes.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878472"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Gentian Violet can cause ulceration of mucous membranes in neonates and young infants. Case reports in infants using 1% or 2% gentian violet suggest that application for as little as 4 days may lead to ulceration, which can be masked by the purple staining. Mechanism for ulceration is unclear; it may be related to alcohol content or direct irritating effect of gentian violet. Close monitoring is recommended; some experts suggest limiting the use of gentian violet to once or twice daily and only using for a short period of time (Leung 1988; Piatt 1992; Slotkowski 1957; Slotkowski 1966). Some products may contain alcohol (up to 10%); use caution when using on infants and children.</p></div>
<div class="block foc drugH1Div" id="F176028"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (59 mL); 2% (59 mL, 59.14 mL)</p></div>
<div class="block geq drugH1Div" id="F176015"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16323170"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Gentian Violet External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $0.14</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per mL): $0.27</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F5184555"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;">
<b>Topical:</b> Clean the affected area prior to application. Apply directly to the wound or with a cotton applicator. Do not cover with bandage. Avoid contact with eyes.</p></div>
<div class="block admp drugH1Div" id="F52612915"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical:</p>
<p style="text-indent:-2em;margin-left:2em;">Dermal/skin: Clean the affected area prior to application. Apply directly to the wound or with cotton; do not apply to ulcerative lesions. Do not cover with bandage; keep affected area dry and exposed to air.</p>
<p style="text-indent:-2em;margin-left:2em;">Oral candidiasis mouth lesions: Apply topically to affected areas in the mouth. For infants, apply sparingly after feedings.</p></div>
<div class="block use drugH1Div" id="F176029"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Topical infection:</b> Treatment of abrasions, minor cuts, surface injuries, and superficial infections of the skin.</p></div>
<div class="block off-label drugH1Div" id="F56228478"><span class="drugH1">Use: Off-Label: Adult</span><p>Oropharyngeal candidiasis, mild disease</p></div>
<div class="block mst drugH1Div" id="F6052748"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Gentian violet may be confused with gentamicin</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299399"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F176024"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block brc drugH1Div" id="F16265830"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">Due to the potential for serious adverse reactions in the nursing infant, breast-feeding is not recommended; safer alternatives for topical skin infections are available (Stoukides, 1993).</p></div>
<div class="block pha drugH1Div" id="F176018"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Topical antiseptic/germicide effective against some vegetative gram-positive bacteria, particularly <i>Staphylococcus</i> sp, and some yeast; it is much less effective against gram-negative bacteria and is ineffective against acid-fast bacteria</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58843390"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Methylrosanilinum chloride</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-HHS.1">
<a name="HHS.1"></a>Candidiasis (Mucocutaneous). In: US Department of Health and Human Services (HHS) Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. <a href="https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf" target="_blank">https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf</a>. Updated May 26, 2020. Accessed June 16, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2272286">
<a name="2272286"></a>Docampo R, Moreno SN. The metabolism and mode of action of gentian violet. <i>Drug Metab Rev</i>. 1990;22(2-3):161-178. doi:10.3109/03602539009041083<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/gentian-violet-drug-information/abstract-text/2272286/pubmed" id="2272286" target="_blank">2272286</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Faber HK, Clark EB. Prevention and treatment of thrush (oidial stomatitis). <i>Am J Dis Child</i>. 1927;34(3):408-417.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Gal.2007">
<a name="Gal.2007"></a>Gal P, Reed M. Medications. In: Kliegman RM, Behrman RE, Jenson HB, et al, eds. <i>Nelson Textbook of Pediatrics</i>. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007: 2955-2999.</div>
</li>
<li>
<div class="reference">
                  Gentian violet 1% [prescribing information]. Texarkana, TX: Humco; October 2013.</div>
</li>
<li>
<div class="reference">
                  Gentian violet 2% [prescribing information]. Texarkana, TX: Humco; March 2019.</div>
</li>
<li>
<div class="reference">
                  Health Canada Advisory. Summary safety review - gentiane violet liquid topical (gentian violet) and hydrofera antibacterial foam dressings. <a href="https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&amp;linkID=SSR00224" target="_blank">https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&amp;linkID=SSR00224</a>. Published June 11, 2019. Accessed May 21, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20791427">
<a name="20791427"></a>John RW. Necrosis of oral mucosa after local application of crystal violet. <i>Br Med J</i>. 1968;1(5585):157-158.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/gentian-violet-drug-information/abstract-text/20791427/pubmed" id="20791427" target="_blank">20791427</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3368270">
<a name="3368270"></a>Leung AK. Gentian violet in the treatment of oral candidiasis. <i>Pediatr Infect Dis J</i>. 1988;7(4):304-305.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/gentian-violet-drug-information/abstract-text/3368270/pubmed" id="3368270" target="_blank">3368270</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27677161">
<a name="27677161"></a>Mukherjee PK, Chen H, Patton LL, et al; Oral HIVAIDS Research Alliance (OHARA) AIDS Clinical Trials Group (ACTG) 5265 Team. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. <i>AIDS</i>. 2017;31(1):81-88. doi:10.1097/QAD.0000000000001286<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/gentian-violet-drug-information/abstract-text/27677161/pubmed" id="27677161" target="_blank">27677161</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1451385">
<a name="1451385"></a>Piatt JP, Bergeson PS. Gentian violet toxicity. <i>Clin Pediatr (Phila)</i>. 1992;31(12):756-757.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/gentian-violet-drug-information/abstract-text/1451385/pubmed" id="1451385" target="_blank">1451385</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Slotkowski EL. Formation of mucous membrane lesions secondary to prolonged use of one per cent aqueous gentian violet. <i>Journal of Pediatrics</i>. 1957:652-654.</div>
</li>
<li>
<div class="reference">
                  Slotkowski EL, Redondo D. Mucosal irritation following use of gentian violet. <i>JAMA</i>. 1966:112;40-42.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8260040">
<a name="8260040"></a>Stoukides C, "Topical Medications and Breastfeeding," <i>J Hum Lact</i>, 1993, 9(3):185-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/gentian-violet-drug-information/abstract-text/8260040/pubmed" id="8260040" target="_blank">8260040</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 8749 Version 119.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
